DRD2, dopamine receptor D2, 1813

N. diseases: 437; N. variants: 42
Disease: Parkinsonian Disorders ×
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0242422
Disease: Parkinsonian Disorders
Parkinsonian Disorders 		0.500 Biomarker group RGD [Effect of Bushen Huoxue Decoction on dopamine D2 receptor in the brain of rats with Parkinson's disease]. 22126770 2011
CUI: C0242422
Disease: Parkinsonian Disorders
Parkinsonian Disorders 		0.500 Biomarker group CTD_human Thiethylperazine-induced parkinsonism: in vivo demonstration of dopamine D2 receptors blockade. 15469457 2004
CUI: C0242422
Disease: Parkinsonian Disorders
Parkinsonian Disorders 		0.500 Therapeutic group CTD_human Thiethylperazine-induced parkinsonism: in vivo demonstration of dopamine D2 receptors blockade. 15469457 2004
CUI: C0242422
Disease: Parkinsonian Disorders
Parkinsonian Disorders 		0.500 Therapeutic group CTD_human Dopamine D2S and D2L receptors may differentially contribute to the actions of antipsychotic and psychotic agents in mice. 12476322 2002
CUI: C0242422
Disease: Parkinsonian Disorders
Parkinsonian Disorders 		0.500 Biomarker group CTD_human Dopamine D2S and D2L receptors may differentially contribute to the actions of antipsychotic and psychotic agents in mice. 12476322 2002
CUI: C0242422
Disease: Parkinsonian Disorders
Parkinsonian Disorders 		0.500 Therapeutic group CTD_human Substituted hexahydrobenzo[f]thieno[c]quinolines as dopamine D1-selective agonists: synthesis and biological evaluation in vitro and in vivo. 9171869 1997
CUI: C0242422
Disease: Parkinsonian Disorders
Parkinsonian Disorders 		0.500 Biomarker group CTD_human Substituted hexahydrobenzo[f]thieno[c]quinolines as dopamine D1-selective agonists: synthesis and biological evaluation in vitro and in vivo. 9171869 1997